Shreshtha Banga1, Vikram Datta2, Harmeet Singh Rehan3, Bhanu Kiran Bhakhri4. 1. Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India 110001. 2. Department of Neonatology, Lady Hardinge Medical College, New Delhi, India 110001. 3. Department of Pharmacology, Lady Hardinge Medical College, New Delhi, India 110001. 4. Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India 110001 drbhanu04@gmail.com.
Abstract
BACKGROUND: Safety of oral sucrose, commonly used procedural analgesic in neonates, is questioned. AIM: To evaluate the effect of sucrose analgesia, for repeated painful procedures, on short-term neurobehavioral outcome of preterm neonates. METHODS:Stable preterm neonates were randomized to receive either sucrose or distilled water orally, for every potentially painful procedure during the first 7 days after enrollment. Neurodevelopmental status at 40 weeks postconceptional age (PCA) measured using the domains of Neurobehavioral Assessment of Preterm Infants scale. RESULTS: A total of 93 newborns were analyzed. The baseline characteristics of the groups were comparable. No statistically significant difference was observed in the assessment at 40 weeks PCA, among the groups. Use of sucrose analgesia, for repeated painful procedures on newborns, does not lead to any significant difference in the short-term neurobehavioral outcome.
RCT Entities:
BACKGROUND: Safety of oral sucrose, commonly used procedural analgesic in neonates, is questioned. AIM: To evaluate the effect of sucroseanalgesia, for repeated painful procedures, on short-term neurobehavioral outcome of preterm neonates. METHODS: Stable preterm neonates were randomized to receive either sucrose or distilled water orally, for every potentially painful procedure during the first 7 days after enrollment. Neurodevelopmental status at 40 weeks postconceptional age (PCA) measured using the domains of Neurobehavioral Assessment of Preterm Infants scale. RESULTS: A total of 93 newborns were analyzed. The baseline characteristics of the groups were comparable. No statistically significant difference was observed in the assessment at 40 weeks PCA, among the groups. Use of sucroseanalgesia, for repeated painful procedures on newborns, does not lead to any significant difference in the short-term neurobehavioral outcome.